SCHEMBL3837759

SCHEMBL3837759

O=C(O)C(Nc1ccc(-n2c(=O)[nH]c3ccccc3c2=O)cc1)c1ccc(Cl)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 4/20 0.47
▸ GAA P10253 3/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ NPC1 O15118 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ HSD17B10 Q99714 4/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ MAPT P10636 5/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ P2RY12 Q9H244 1/20 0.40
▸ HTT P42858 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ PDE7A Q13946 1/20 0.38
▸ PDE7B Q9NP56 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1639714 0.87 GAA (0.48) TP53GAAKDM4ENPC1SMN1; SMN2
SCHEMBL1640093 0.78 P2RY12 (0.44) TP53GAAKDM4ENPC1SMN1; SMN2
SCHEMBL1639024 0.76 P2RY12 (0.37) TP53GAAKDM4ENPC1SMN1; SMN2
SCHEMBL3834826 0.76 F10 (0.34) GAA
SCHEMBL3834891 0.75 GAA (0.38) TP53GAAKDM4ESMN1; SMN2ALDH1A1
SCHEMBL6983353 0.74 TP53 (0.58) TP53GAAKDM4ENPC1SMN1; SMN2
SCHEMBL3838454 0.74 P2RY12 (0.54) TP53GAAKDM4ESMN1; SMN2HSD17B10
SCHEMBL6982187 0.74 GAA (0.59) TP53GAAKDM4ENPC1SMN1; SMN2
SCHEMBL1640201 0.73 P2RY12 (0.68) TP53KDM4ESMN1; SMN2HSD17B10ALDH1A1
SCHEMBL1640664 0.73 SMN1; SMN2 (0.38) TP53GAAKDM4ENPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2094272-A2 NITROGEN CONTAINING SUBSTITUTED HETEROCYCLES AS PLATELET ADP RECEPTOR INHIBITORS Portola Pharmaceuticals, Inc. (US) 2009-09-02 — — EP disclosed
WO-2008036843-A2 NITROGEN CONTAINING SUBSTITUTED HETEROCYCLES AS PLATELET ADP RECEPTOR INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2008-03-27 — — WO disclosed
Send feedback